BPC-157 Reconstitution & Dosing Calculator: BAC Water Math, Syringe Marks & Common Mistakes

✓ Medically reviewed by  ·  Last reviewed: May 2026

Morgan Ellis

Pharmacy Researcher · 8 years experience

Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.

This guide is a focused companion to our broader BPC-157 Peptide: Healing, Dosage & Safety Guide. The healing-and-safety piece covers what BPC-157 is and what the animal and early human data actually show; this one is the practical reconstitution and dosing math you need before the cap comes off the vial. Both are written for research-use buyers — the legal and clinical framing for human therapeutic use of BPC-157 is unsettled in most jurisdictions, and nothing here is medical advice.

What You Actually Need on the Bench

A reconstitution station is short. There are five items, and skipping any of them is a quality control failure.

1. The BPC-157 vial itself. Sealed, lyophilised, sitting at the bottom of the glass as a small white puck or thin film. Our research-grade BPC-157 ships as 5 mg per vial with a HPLC certificate of analysis (≥99% purity, CAS-keyed) — that 5 mg/vial format is the assumption used in every calculation below. If you have a different size (2 mg or 10 mg vials are also sold), the math scales linearly.
2. Bacteriostatic water. Not sterile water for injection, not distilled water, not saline. BAC water contains 0.9% benzyl alcohol, which is what gives a reconstituted vial its ~28-day shelf life. Plain sterile water doesn’t have a bacteriostat — a multi-dose vial reconstituted with it should be used within 24 hours.
3. A U-100 insulin syringe with a 29–31 G half-inch needle. Insulin syringes are calibrated in “units” where 100 units = 1.0 mL. This calibration is the thing that makes peptide dosing tolerable — you’ll be measuring volumes between 0.05 mL and 0.5 mL, and a 3 mL syringe simply doesn’t have the resolution.
4. Alcohol prep pads, paper towel, sharps container. Pad the vial septum and the injection site before each draw. The sharps container is for the needle after a single use — needles get reused only at the cost of dulling and bacterial seeding.
5. Refrigerator at 2–8 °C. Not the freezer. Not the door (which cycles to 10 °C every time you open it). The body of the fridge, ideally on a shelf away from the back wall where freezer ice can form.

If any of this is missing, the answer is to wait until it’s there — improvising “I’ll use a 1 mL syringe and eyeball it” is the path to a 5× dosing error.

The Reconstitution Math, in Plain Numbers

Here is the only formula you need. Memorise it:

Concentration (mcg per insulin “unit”) = Total peptide (mcg) ÷ (mL of BAC water added × 100)

Why “× 100”? Because a U-100 insulin syringe has 100 marks per mL. So if you add 1 mL of BAC water, every “unit” on the syringe is 1/100 of an mL. Multiply by your peptide concentration and you get mcg per unit.

Worked through for the common 5 mg (= 5,000 mcg) BPC-157 vial:

Read the table this way: pick the row whose “250 mcg” or “500 mcg” column gives a whole number of units. That’s the volume of BAC water you want to add. The 2.0 mL row is the friendliest for most protocols — 10 units = 250 mcg, 20 units = 500 mcg, and you never have to read half-marks.

Two volume notes that trip people up:

• BAC water adds, peptide doesn’t. The 5 mg of powder occupies a negligible volume in solution. The final liquid volume in the vial is essentially equal to the BAC water you added.
• Don’t squirt the BAC water onto the powder. Tilt the vial 45° and let the water run down the inside glass wall — direct impact can foam the peptide and tear the bonds. Then leave the vial alone for 60 seconds and swirl gently. Never shake.

Reading the Syringe Marks

A U-100 insulin syringe usually shows the scale as 0 → 100 units, with major marks every 10 units and minor marks every 2 units. Some syringes (sold as U-50 or “low dose”) run 0 → 50 with marks every 1 unit. Both are calibrated to U-100 insulin — the difference is just where the maximum is.

Three guardrails when drawing:

1. Pull air into the syringe equal to the dose you’re about to take, then inject it into the vial first. This equalises pressure so the plunger pulls out smoothly. Skipping this is the reason your dose came up “short” by 1–2 units.
2. Invert the vial and pull slowly past your target mark, then push back to the exact line. The “push back” step gets rid of micro-bubbles trapped at the needle hub.
3. Tap, don’t shake. Big bubble at the top of the syringe? Hold needle-up and tap the barrel until it rises to the top, then push it back into the vial. A bubble at the bottom (near the needle) is the one that throws your dose off — get rid of it before withdrawing the needle.

Common Dosing Protocols at a Glance

The published rodent literature on BPC-157 uses doses in the 10 mcg/kg range. Translating that to a 70 kg human gives ~700 mcg — but human bioavailability data is limited, and most user protocols converge to a tighter window. Three patterns that appear repeatedly in the research-user community:

The aggressive column is almost exclusively used in the first 1–3 weeks following an acute musculoskeletal event (a tendon micro-tear, a post-surgical recovery window) and then tapered down. Sustained dosing above 500 mcg/day for many months has no evidence base — the published mechanism work in animals shows efficacy at much lower equivalent doses, and “more” is not the same as “better”.

If you are stacking BPC-157 with a sister peptide like TB-500 (Thymosin Beta-4) for compound healing, our BPC-157 vs TB-500 comparison guide walks through the mechanistic case and the practical co-dosing schedule. The pre-mixed BPC-157 + TB-500 blend skips the math entirely for users who want a single-vial protocol.

Oral, Subcutaneous, Intramuscular — Which Route When?

BPC-157 has been studied in three administration routes. Each has a use case and a trade-off.

The most common error here is using oral BPC-157 for a tendinopathy and concluding “BPC-157 doesn’t work.” It works — for that protocol — about as well as a sugar pill, because almost none of it crosses the gut wall intact. Match the route to the target.

For subcutaneous injections, the abdomen 2 inches lateral to the navel is the standard site — pinch a fold of skin, insert at 45° (or 90° if you have a half-inch needle and decent subcutaneous fat), inject slowly over 5–10 seconds, hold pressure with a clean cotton ball for 30 seconds. Rotate sites between the four abdominal quadrants to avoid local irritation.

Storage, Stability & the 28-Day Rule

A reconstituted BPC-157 vial follows the same general stability profile as other research peptides reconstituted in bacteriostatic water:

• Unreconstituted (lyophilised powder): 24+ months at –20 °C, 12+ months at 2–8 °C. Don’t open until you’re ready to use.
• Reconstituted with BAC water: ~28 days at 2–8 °C (the benzyl alcohol in BAC water gives you the 28-day stability window). Practical handling rule: finish the vial within 28 days of reconstitution. If you’ve added 2 mL of BAC to a 5 mg vial and you’re dosing 500 mcg/day, that’s a 10-day vial — well within the window.
• Reconstituted with plain sterile water: Use within 24 hours. No bacteriostat = no shelf life.
• Room temperature: Less than 30 minutes for in-use handling. Take the vial out, draw the dose, return to the fridge.
• Freezing the reconstituted vial: Don’t. Each freeze-thaw cycle introduces micro-shears that break peptide bonds. The vial will look fine and dose like a placebo.
• Light: BPC-157 is light-sensitive — keep the vial in its box or a paper bag in the fridge, not on an open shelf.

If you want a deeper walkthrough on BAC water itself — what it is, why benzyl alcohol matters, when to swap it for plain sterile water — our BAC water reconstitution and storage guide covers it end-to-end.

The Seven Most Common Reconstitution & Dosing Mistakes

1. Reading the syringe in mL instead of units. A 10-unit mark on a U-100 insulin syringe is 0.10 mL. People misread it as “10 mL” or “10 marks past zero” and end up off by 5× or 10×. Use the table above and convert once when you reconstitute, then dose in units forever after.
2. Using a 1 mL or 3 mL syringe. The resolution isn’t there for sub-100 mcg doses. Always U-100 insulin.
3. Adding BAC water by squirting the powder. Foams the peptide, breaks bonds. Tilt and run it down the wall.
4. Shaking the vial to mix. Same problem — denatures the peptide. Gentle swirl, then 60 seconds rest.
5. Treating mcg and mg interchangeably. 1 mg = 1,000 mcg. A “500” you wrote on the vial label could mean 500 mcg (a real dose) or 500 mg (a wildly impossible dose). Write the unit every time.
6. Letting the vial sit at room temperature between doses. 30-minute maximum out-of-fridge time. The peptide degrades faster than the bacteriostat can protect against contamination.
7. Reusing the needle. Insulin needles are designed for one use. By the second draw they’re dull (painful), and by the fourth they’re a contamination risk. Sharps container after each injection.

Where to Source (and What “Research-Grade” Actually Means)

Peptide quality is the variable nobody controls until it’s too late. The minimum standard worth paying for:

• HPLC purity ≥99% on a per-lot certificate of analysis — not a generic statement, an actual analytical chromatogram with a lot number that matches your vial.
• CAS number on the label (137525-51-0 for BPC-157) so you can verify you have what was ordered.
• Mass spectrometry confirmation (the molecular weight should be 1,419.5 Da — ±2 Da is normal analytical noise; ±50 Da means you have a different peptide).
• Lyophilised, not solution. A vial that arrives as liquid was reconstituted by the seller — you have no way of knowing when, with what, or how it was stored.
• Cold-chain shipping for the powder is optional but a sign of seriousness on the seller’s side.

If you’re new to the broader peptide-research catalogue, our best peptides for muscle recovery hub covers BPC-157, TB-500, GHK-Cu, and the pragmatic stack options, and the full peptides category lists everything in stock with the same HPLC/COA documentation. The BPC-157 + TB-500 + BAC water bundle is the lowest-friction way to start if you want everything in one shipment.

Frequently Asked Questions

How much BAC water should I add to a 5 mg BPC-157 vial?

Two millilitres is the most user-friendly answer. It gives you 2,500 mcg/mL — a 250 mcg dose is 10 units on a U-100 insulin syringe, and a 500 mcg dose is 20 units. Both are whole numbers on the major marks, with zero math required at draw time. One millilitre works if you want to inject very small volumes (5 units for 250 mcg) and 2.5 mL works if you want each unit to equal exactly 20 mcg.

How long does a reconstituted BPC-157 vial last in the fridge?

About 28 days, which is the established stability window for peptides reconstituted in 0.9% benzyl alcohol bacteriostatic water and kept at 2–8 °C. Track the date on the vial label. Past 28 days, you’re not in a sudden cliff — there’s no flash failure — but published stability data thins out and the conservative answer is to start a new vial.

Can I freeze the reconstituted vial to make it last longer?

No. Freezing reconstituted peptide solutions and then thawing them introduces ice-crystal micro-shears that break peptide bonds. Each freeze-thaw cycle drops your effective potency. The lyophilised powder can be frozen at –20 °C for long-term storage; the solution cannot.

What’s the difference between mg and mcg on the label?

1 milligram (mg) equals 1,000 micrograms (mcg). A standard BPC-157 vial is labelled “5 mg” = 5,000 mcg of total peptide. Daily doses are typically expressed in mcg (e.g., 250 mcg, 500 mcg) because the actual amount delivered is small.

What size needle and syringe should I use?

A U-100 insulin syringe with a 29–31 gauge, half-inch needle is the standard. The 29G is fine for most people; 31G is slightly less uncomfortable but slower to draw. The half-inch length is long enough for subcutaneous abdominal injection at 45° in lean adults; very lean users sometimes prefer 5/16-inch.

Should I inject BPC-157 near the injury site or anywhere on the abdomen?

Both routes are used. Abdominal subcutaneous injection delivers a systemic dose that will reach injured tissue through circulation. Site-adjacent subcutaneous injection (e.g., near an injured tendon) is preferred by some researchers on the theory that local concentration matters — but high-quality comparative trials between the two routes don’t exist in humans. The honest answer: pick whichever is sustainable for daily use, because consistency over the protocol matters more than the exact injection site.

Can I take BPC-157 orally instead of injecting it?

For gut-specific research applications, yes — oral BPC-157 has documented local effects on the gastrointestinal lining in animal models. For everything else (tendon, joint, soft tissue, neuroprotection), no — systemic bioavailability of oral BPC-157 in humans is very low, and the dose-response data we have is built on injectable administration. Capsule BPC-157 is the wrong tool for a hamstring tendinopathy; it is the right tool for an ulcer-model research protocol.

How long until I notice an effect?

The user-reported window is 7–14 days for soft-tissue effects, with 4–6 weeks being the typical protocol length before evaluating outcome. Faster timelines (24–48 hours) almost always reflect concomitant rest, NSAID use, or natural inflammatory cycle rather than the peptide. The animal literature shows histological effects within days; whether that maps onto subjective human pain reports is exactly the unsettled question that limits BPC-157’s clinical adoption.

Does BPC-157 need to be cycled?

There’s no pharmacological evidence that tolerance develops with continuous use, but the practical convention in the research-user community is 4–6 weeks on followed by 2–4 weeks off. The reasoning is more about catching adverse responses early and avoiding unnecessary continuous exposure than about preserving sensitivity.

Where can I read more about BPC-157’s mechanism and the research base?

Our BPC-157 Peptide: Healing, Dosage & Safety Guide covers the mechanism (angiogenic signalling, growth-factor upregulation, nitric-oxide pathway), the animal data, the human evidence gap, and the safety profile in depth. This page is the practical reconstitution companion to that.

Closing Note

BPC-157 dosing is, mechanically, very simple — a U-100 insulin syringe, a 5 mg vial, 2 mL of BAC water, and a 10-second injection. What goes wrong is almost never the peptide; it’s the math, the syringe-mark misread, or letting the vial sit at room temperature for an afternoon. Get the table above bookmarked, write the date and concentration on the vial cap with a marker, and the rest is just calendar discipline.

If you’d rather skip the math entirely, the BPC-157 + TB-500 blend vial pairs the two healing peptides in a pre-calibrated ratio, and the peptide healing stack bundle ships BPC-157, TB-500, and BAC water together in one box — same lot-number COAs, one shipment to chase, no per-item shipping decisions.

Written by Sophie Chen for MedsBase. Sophie covers peptide protocols, dosing math, and the practical handling questions that don’t show up on the spec sheet. For BPC-157’s broader mechanism, evidence base, and safety profile, see our full healing-and-recovery guide. For sister peptides and combination protocols, our muscle-recovery hub and full peptides catalogue are the starting points.

Written by

Sophie Chen

Pharmaceutical Content Researcher · 8 years experience

Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.